LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Antiviral Development Cocrystal Pharma specializes in discovering and developing novel antiviral therapeutics targeting coronavirus, influenza, and noroviruses, presenting opportunities to collaborate or supply advanced antiviral compounds to healthcare providers and governments seeking pandemic preparedness.

Clinical Progress Opportunities With ongoing Phase 1 trials for influenza and upcoming COVID-19 clinical studies, there is potential to engage with the company for clinical trial services, medical supplies, or partnership opportunities to accelerate development pipelines.

Strong Funding and Visibility Recent financing of $4.7 million and participation in prominent investment conferences suggest increasing investor interest and growth potential, making Cocrystal a compelling partner for pharmaceutical investments, licensing, or strategic alliances.

Strategic Industry Engagement The company's active participation in multiple industry events and conferences provides opportunities to build relationships, present joint research collaborations, or explore co-marketing strategies within the biotech and healthcare sectors.

Technology and Data Utilization Cocrystal employs advanced technology stacks including AWS, cloud services, and analytics tools, indicating an openness to partnerships involving digital health, data management, or AI-driven research collaborations to enhance drug discovery and development.

Cocrystal Pharma, Inc. Tech Stack

Cocrystal Pharma, Inc. uses 8 technology products and services including Amazon Web Services, Microsoft 365, Modernizr, and more. Explore Cocrystal Pharma, Inc.'s tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Microsoft 365
    Email
  • Modernizr
    Javascript Libraries
  • Cloudflare Bot Management
    Security
  • Bootstrap
    UI Frameworks
  • Google Analytics
    Web Analytics
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers

Media & News

Cocrystal Pharma, Inc.'s Email Address Formats

Cocrystal Pharma, Inc. uses at least 1 format(s):
Cocrystal Pharma, Inc. Email FormatsExamplePercentage
FLast@cocrystalpharma.comJDoe@cocrystalpharma.com
82%
Last@cocrystalpharma.comDoe@cocrystalpharma.com
11%
LFirst@cocrystalpharma.comDJohn@cocrystalpharma.com
5%
LastF@cocrystalpharma.comDoeJ@cocrystalpharma.com
2%

Frequently Asked Questions

Where is Cocrystal Pharma, Inc.'s headquarters located?

Minus sign iconPlus sign iconCocrystal Pharma, Inc.'s main headquarters is located at 19805 N. Creek Parkway, Bothell, Washington 98011, US. The company has employees across 1 continents, including North America.

What is Cocrystal Pharma, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Cocrystal Pharma, Inc.'s main corporate office by phone at
+1-678-892-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cocrystal Pharma, Inc.'s stock symbol?

Minus sign iconPlus sign iconCocrystal Pharma, Inc. is a publicly traded company; the company's stock symbol is COCP.

What is Cocrystal Pharma, Inc.'s official website and social media links?

Minus sign iconPlus sign iconCocrystal Pharma, Inc.'s official website is cocrystalpharma.com and has social profiles on LinkedInCrunchbase.

What is Cocrystal Pharma, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconCocrystal Pharma, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cocrystal Pharma, Inc. have currently?

Minus sign iconPlus sign iconAs of October 2025, Cocrystal Pharma, Inc. has approximately 14 employees across 1 continents, including North America. Key team members include Chief Executive Officer: J. M.Cmo: G. M.Vice President Business Operations: B. O.. Explore Cocrystal Pharma, Inc.'s employee directory with LeadIQ.

What industry does Cocrystal Pharma, Inc. belong to?

Minus sign iconPlus sign iconCocrystal Pharma, Inc. operates in the Biotechnology Research industry.

What technology does Cocrystal Pharma, Inc. use?

Minus sign iconPlus sign iconCocrystal Pharma, Inc.'s tech stack includes Amazon Web ServicesMicrosoft 365ModernizrCloudflare Bot ManagementBootstrapGoogle AnalyticsApacheApache HTTP Server.

What is Cocrystal Pharma, Inc.'s email format?

Minus sign iconPlus sign iconCocrystal Pharma, Inc.'s email format typically follows the pattern of FLast@cocrystalpharma.com. Find more Cocrystal Pharma, Inc. email formats with LeadIQ.

How much funding has Cocrystal Pharma, Inc. raised to date?

Minus sign iconPlus sign icon As of October 2025, Cocrystal Pharma, Inc. has raised $4M in funding. The last funding round occurred on Apr 10, 2023 for $4M.

Cocrystal Pharma, Inc.

Biotechnology ResearchUnited States11-50 Employees

Cocrystal Pharma, Inc. (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of COVID-19 and other coronaviruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. 

The company is enrolling subjects in a Phase 1 trial with an antiviral candidate for pandemic and seasonal influenza A, and plans to initiate COVID-19 clinical trials in 2022 with an orally administered and inhalation/pulmonary delivered antiviral candidates.

Section iconCompany Overview

Headquarters
19805 N. Creek Parkway, Bothell, Washington 98011, US
Phone number
+1-678-892-****
Website
cocrystalpharma.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
COCP
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $4M

    Cocrystal Pharma, Inc. has raised a total of $4M of funding over 6 rounds. Their latest funding round was raised on Apr 10, 2023 in the amount of $4M.

  • $1M$10M

    Cocrystal Pharma, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $4M

    Cocrystal Pharma, Inc. has raised a total of $4M of funding over 6 rounds. Their latest funding round was raised on Apr 10, 2023 in the amount of $4M.

  • $1M$10M

    Cocrystal Pharma, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    J. M.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. M.
    Cmo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. O.
    Vice President Business Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    Vice President - Research
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. T.
    President And Chief Executive Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    W. O.
    Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. O.
    Vice President Business Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. C.
    Vice President - Research
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. P.
    Vice-President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. J.
    Independent Director On The Board Of Directors
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.